NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: VEEA 30.24%
Veea Shares Surge After Launch of TerraFabric Edge Computing Platform
NASDAQ: DLLL 42.51%
US Companies Moving the Markets, Evening edition Fri, Feb 27, 2026 as of 4:00 pm ET
NASDAQ: KORE 21.95%
NASDAQ: ACXIF 21.95%
NASDAQ: CDIO 21.95%
NASDAQ: NGNE 21.95%
NASDAQ: VEEA 21.95%
